MedTrace Logo

Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence

NCT00548275 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2020-04-03

No results posted yet for this study

Summary

The major goal is to determine in patients entering buprenorphine treatment, the prevalence of specific sex-related HIV risk behaviors, their physician's screening of these behaviors and to evaluate the impact of risk reduction counseling.

Conditions

  • Opiate Dependence
  • HIV Infections

Interventions

BEHAVIORAL

Enhanced Sexual Risk Management

management of sexual risk

BEHAVIORAL

Standard Sexual Risk Management

management of sexual risk

Sponsors & Collaborators

  • Robert Wood Johnson Foundation

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Lynn E Sullivan, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00548275 on ClinicalTrials.gov